United States Ophthalmic Market expected to reach $36.50 billion by 2031.

From GlobeNewswire: 2024-05-20 19:10:00

CoherentMI’s report reveals the United States Ophthalmic Market was valued at US$ 15.90 Billion in 2023, projected to reach US$ 36.50 Billion by 2031, growing at a CAGR of 8.6%. Factors driving growth include the rising prevalence of eye diseases, growing geriatric population, technological advancements, and increased healthcare expenditure.

The market is expected to witness significant growth opportunities, with key players like Novartis AG and Merck & Co., Inc. focusing on product innovation and strategic partnerships. Trends in the market include the adoption of advanced surgical techniques and personalized medicine in ophthalmology.

Market opportunities lie in the rising demand for anti-inflammatory drugs and the surge in online pharmacies for ophthalmic products. Segmentation includes drug class, dosage form, indication, distribution channel, and region, with eye drops, hospital pharmacies, and North America expected to lead the market.

Key questions answered in the report include factors impeding market growth, primary drivers fueling growth, leading market segments, key players, region projections, and projected CAGR. Other trending reports by CoherentMI cover the United States Pharmaceuticals Market, Global Feeding Tubes Market, and Global Undescended Testicle Market.



Read more at GlobeNewswire: United States Ophthalmic Market Size to Surpass Around US$